Pay in 4 interest-free payments of $5.99 Learn more
Ships within 48 hours · Estimated delivery Aug 9 - Aug 14
Quality control analysis and quantification of the sequencing library were performed using Agilent Technologies 2100 Bioanalyzer High Sensitivity DNA Chip (Cat #5067-5592)
To generate Trim37 knockout PGCs in Nanog-EGFP transgenic embryos, we designed an sgRNA targeting exon 5 of Trim37 (Supplementary information, Fig
PubMed laboratory research record [PMID: 12563618] PubMed record related to this compound for laboratory literature review
Alcohol prep required: Clean the injection site with alcohol before each injection (DailyMed label) 3 DailyMed-Approved Sites Once weekly Dosing Frequency ~6 days Half-Life (supports weekly schedule) Investigational compound: Retatrutide (LY3437943) has not received FDA approval as of April 2026
For example: customized hormone replacement therapy that addresses lack of energy and treats issues like bone loss and increased fracture risk in post-menopausal women
Most anti-aging peptides hit one layer
